131 related articles for article (PubMed ID: 36571909)
1. Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System.
Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
Cancer Epidemiol; 2023 Feb; 82():102316. PubMed ID: 36571909
[TBL] [Abstract][Full Text] [Related]
2. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
[TBL] [Abstract][Full Text] [Related]
3. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer survival among black and white patients in an equal access health system.
Zheng L; Enewold L; Zahm SH; Shriver CD; Zhou J; Marrogi A; McGlynn KA; Zhu K
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1841-7. PubMed ID: 22899731
[TBL] [Abstract][Full Text] [Related]
5. Bone metastatic cancer of unknown primary at initial presentation.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
[TBL] [Abstract][Full Text] [Related]
6. Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER.
Lin J; Orestes MI; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):426-434. PubMed ID: 38099827
[TBL] [Abstract][Full Text] [Related]
7. Survival among Black and White patients with renal cell carcinoma in an equal-access health care system.
Lin J; Zahm SH; Shriver CD; Purdue M; McGlynn KA; Zhu K
Cancer Causes Control; 2015 Jul; 26(7):1019-26. PubMed ID: 25956269
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
9. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
10. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
11. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
Lin J; Hu H; Shriver CD; Zhu K
Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
[TBL] [Abstract][Full Text] [Related]
12. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
Lin J; McGlynn KA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
[TBL] [Abstract][Full Text] [Related]
14. A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.
Ross RB; Koyfman SA; Reddy CA; Houston N; Geiger JL; Woody NM; Joshi NP; Greskovich JF; Burkey BB; Scharpf J; Lamarre ED; Prendes B; Lorenz RR; Adelstein DJ; Ward MC
Laryngoscope; 2018 Jun; 128(6):1379-1385. PubMed ID: 29086413
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pancreatic adenocarcinoma in relation to survival in the U.S. Military Health System.
Eaglehouse YL; Darmon S; Park AB; Shriver CD; Zhu K
Cancer Epidemiol; 2024 Feb; 88():102520. PubMed ID: 38184935
[TBL] [Abstract][Full Text] [Related]
16. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system.
Jatoi I; Becher H; Leake CR
Cancer; 2003 Sep; 98(5):894-9. PubMed ID: 12942554
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
[TBL] [Abstract][Full Text] [Related]
18. Colon cancer lymph node evaluation among military health system beneficiaries: an analysis by race/ethnicity.
Gill AA; Zahm SH; Shriver CD; Stojadinovic A; McGlynn KA; Zhu K
Ann Surg Oncol; 2015 Jan; 22(1):195-202. PubMed ID: 25059789
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in survival among women with endometrial cancer in an equal access system.
Park AB; Darcy KM; Tian C; Casablanca Y; Schinkel JK; Enewold L; McGlynn KA; Shriver CD; Zhu K
Gynecol Oncol; 2021 Oct; 163(1):125-129. PubMed ID: 34325938
[TBL] [Abstract][Full Text] [Related]
20. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
